Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.

@article{Bunnapradist2003ControllingTA,
  title={Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.},
  author={Suphamai Bunnapradist and Steven K. Takemoto},
  journal={Transplantation proceedings},
  year={2003},
  volume={35 7},
  pages={2407-8}
}
Previous analyses of outcomes between immunosuppressive regimens included data from the early years of tacrolimus use and frequently included all Tacrolimus- or cyclosporine-based regimens. We now evaluate clinical outcomes associated with only the two most commonly prescribed regimens--Tacrolimus (Tac)-mycophenylate mofetil (MMF) and cyclosporine (CsA)-MMF--using recent data reported to the UNOS Scientific Renal Transplant Registry. Data from living donor kidney transplants was chosen to… CONTINUE READING